Compare LXRX & BCSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXRX | BCSS |
|---|---|---|
| Founded | 1995 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 703.3M | 591.0M |
| IPO Year | 2000 | N/A |
| Metric | LXRX | BCSS |
|---|---|---|
| Price | $2.18 | $10.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.15 | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 110.4K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $49,803,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $0.62 | $10.06 |
| 52 Week High | $2.53 | $10.24 |
| Indicator | LXRX | BCSS |
|---|---|---|
| Relative Strength Index (RSI) | 58.05 | 59.52 |
| Support Level | $1.44 | $10.13 |
| Resistance Level | $2.53 | $10.21 |
| Average True Range (ATR) | 0.17 | 0.01 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 33.96 | 50.00 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Bain Capital GSS Investment Corp is a newly organized blank check company.